Audiology Exam 2 Comprehensive Review

0.0(0)
Studied by 0 people
call kaiCall Kai
learnLearn
examPractice Test
spaced repetitionSpaced Repetition
heart puzzleMatch
flashcardsFlashcards
GameKnowt Play
Card Sorting

1/88

flashcard set

Earn XP

Description and Tags

Comprehensive vocabulary review flashcards for Audiology Exam 2, covering immittance audiometry, tympanometry types, evoked potentials (OAE, ABR), outer/middle/inner ear pathologies, CAPD, embryology, syndromic genetics, hearing aids, and implantable auditory devices.

89 Terms

1
New cards

Impedance

The opposition to the flow of acoustic energy through a physical system.

2
New cards

Admittance

A measure of how much acoustic energy successfully passes through a system.

3
New cards

Tympanometry

The measurement of acoustic admittance (mobility of the tympanic membrane and ossicular chain) as a function of air pressure changes applied in the external ear canal.

4
New cards

Tympanometric Probe Tone Frequencies

A probe tone of 226 Hz226\,\text{Hz} is standard for adults, whereas a high-frequency probe tone of 1000 Hz1000\,\text{Hz} (1 kHz1\,\text{kHz}) is required for infants under 66 months of age.

5
New cards

Tympanic Peak Pressure (TPP)

An indicator of middle ear pressure measured in daPa\text{daPa}, representing the point of maximum sound admittance when pressure in the canal matches the pressure in the middle ear cavity; abnormal negative readings indicate Eustachian tube dysfunction.

6
New cards

Peak Compensated Static Acoustic Admittance (YtmY_{tm})

The maximum mobility or compliance of the tympanic membrane measured in cc\text{cc} (cm3\text{cm}^3) or mL\text{mL}; reduced values suggest scarring or otosclerosis, while abnormally elevated values indicate hypercompliance or disarticulation.

7
New cards

Ear Canal Volume (VeaV_{ea} / ECV)

The equivalent physical volume of air between the probe tip and the tympanic membrane, measured in mL\text{mL}.

8
New cards

Etiologies of Abnormally Large Ear Canal Volume (VeaV_{ea})

A tympanic membrane perforation, a patent pressure equalization (PE) tube, or prior surgical alteration of the ear canal.

9
New cards

Etiologies of Abnormally Small Ear Canal Volume (VeaV_{ea})

Impacted cerumen or debris occluding the canal, a middle ear space-occupying mass, atresia, or probe tip placement directly against the canal wall.

10
New cards

Tympanometric Width (TW)

The pressure interval (reported in daPa\text{daPa}) determined at half the height of the tympanometric peak (12\frac{1}{2} of YtmY_{tm}), calculated as the absolute difference between the two pressure points; abnormal width indicates accumulating or resolving middle ear fluid and is not related to TPP.

11
New cards

Compensated Tympanogram

A tympanometric tracing that subtracts the ear canal volume (VeaV_{ea}) to display only the acoustic admittance contributed by the middle ear system.

12
New cards

Type A Tympanogram

A normal tympanogram characterized by normal middle ear pressure, normal admittance/compliance, normal ear canal volume, and normal tympanometric width.

13
New cards

Type AsA_s Tympanogram

A shallow tympanogram characterized by normal middle ear pressure, normal canal volume, and normal width, but abnormally reduced peak admittance/compliance; associated with ossicular fixation (otosclerosis) or early/resolving otitis media with effusion.

14
New cards

Type AdA_d / AddA_{dd} Tympanogram

A hypercompliant deep tympanogram displaying normal middle ear pressure and canal volume, but abnormally high admittance/compliance; caused by ossicular chain disarticulation or a monomeric/flaccid tympanic membrane.

15
New cards

Type B Tympanogram

A flat tympanogram demonstrating no discernible peak and low-to-no admittance; normal VeaV_{ea} indicates middle ear effusion or severe negative pressure, large VeaV_{ea} indicates a perforation or patent PE tube, and small VeaV_{ea} indicates an occluding obstruction.

16
New cards

Type C Tympanogram

A tympanogram exhibiting normal admittance and normal canal volume, but significant negative middle ear peak pressure (<−100 daPa<-100\,\text{daPa}); primarily indicates Eustachian tube dysfunction.

17
New cards

Acoustic Reflex

An involuntary contraction of the stapedius and tensor tympani middle ear muscles in response to loud acoustic stimulation (≥80 dB\ge 80\,\text{dB}), which stiffens the ossicular chain, attenuates vibrational energy transmission to the cochlea, and protects inner ear structures.

18
New cards

Acoustic Reflex Threshold (ART)

The lowest stimulus intensity level capable of eliciting a measurable decrease in middle ear admittance (≥0.02\ge 0.02), measured with the ear pressurized to its TPP; used primarily to evaluate auditory nerve (CN VIII) and facial nerve (CN VII) pathways and rule out acoustic neuromas.

19
New cards

Otoacoustic Emissions (OAE)

An objective physiologic measure assessing the integrity and active micromechanical electromotility of outer hair cells (OHCs) on the basilar membrane.

20
New cards

Transient Evoked Otoacoustic Emissions (TEOAEs)

OAEs elicited by broadband clicks that simultaneously stimulate multiple frequency regions (∼1000 to 4000 Hz\sim 1000\text{ to }4000\,\text{Hz}); analyzed as a pass/fail screening using signal averaging, requiring high reproducibility and a Signal-to-Noise Ratio (SNR) greater than 6 dB6\,\text{dB}.

21
New cards

TEOAE Hearing Threshold Relationships

TEOAEs are present in 99%99\% of ears with thresholds <20 dB HL< 20\,\text{dB HL}, may or may not be present from 25 to 35 dB HL25\text{ to }35\,\text{dB HL}, and are completely absent (never present) when thresholds exceed 40 dB HL40\,\text{dB HL}.

22
New cards

Distortion Product Otoacoustic Emissions (DPOAEs)

Diagnostic, frequency-specific OAEs generated by presenting two pure tones simultaneously (f1f_1 and f2f_2) to evaluate frequencies from ∼1000 to 6000 Hz\sim 1000\text{ to }6000\,\text{Hz}; requires an SNR greater than 6 dB6\,\text{dB} for a valid response.

23
New cards

DPOAE Hearing Threshold Relationships

DPOAEs are present when hearing thresholds are <25 dB HL< 25\,\text{dB HL}, generally absent when thresholds exceed 40 dB HL40\,\text{dB HL}, and potentially present with reduced amplitude between 40 to 60 dB HL40\text{ to }60\,\text{dB HL}.

24
New cards

Auditory Brainstem Response (ABR)

An objective electrophysiologic test measuring synchronous electrical action potentials generated along the auditory pathway from the cochlea through the brainstem within the first 10 to 12 ms10\text{ to }12\,\text{ms} following stimulus presentation.

25
New cards

ABR Click Stimuli

Loud broadband acoustic pulses that stimulate a wide cochlear region to evaluate neural integrity and interpeak latencies across Waves I through VI; primarily applied in neuro-diagnostic testing for retrocochlear pathology.

26
New cards

ABR Tone Burst Stimuli

Frequency-specific filtered noise bursts presented at 500 Hz500\,\text{Hz}, 1000 Hz1000\,\text{Hz}, 2000 Hz2000\,\text{Hz}, and 4000 Hz4000\,\text{Hz} used to estimate behavioral hearing thresholds by identifying the lowest intensity level that elicits Wave V.

27
New cards

ABR Neural Generators (Waves I–VI)

Wave I: Cochlea/distal CN VIII; Wave II: CN VIII (proximal); Wave III: Cochlear Nucleus; Wave IV: Superior Olivary Complex; Wave V: Lateral Lemniscus; Wave VI: Inferior Colliculus.

28
New cards

Anotia

A congenital disorder characterized by the complete absence of the auricle/pinna.

29
New cards

Microtia

A congenital deformity presenting as an abnormally small or malformed auricle/pinna.

30
New cards

Aural Atresia

A congenital absence or complete closure of the external auditory canal.

31
New cards

Canal Stenosis

An abnormal narrowing of the external auditory canal diameter, which may be congenital or acquired.

32
New cards

Auricular Hematoma

An acquired collection of blood beneath the perichondrium of the pinna resulting from trauma, commonly known as perichondrial hematoma or 'cauliflower ear.'

33
New cards

Otitis Externa

An infectious condition of the external ear canal skin, which may be viral, bacterial, or fungal in origin.

34
New cards

Exostosis

Benign bony outgrowths in the external auditory canal triggered by repeated, prolonged exposure to cold water, commonly termed 'surfer's ear.'

35
New cards

Osteoma

A benign bony neoplasm appearing as a solitary tumor within the external auditory canal.

36
New cards

Otitis Media with Effusion (OME)

An inflammatory condition characterized by the accumulation of fluid within the normally air-filled middle ear space.

37
New cards

Serous Otitis Media

A form of middle ear effusion where thin, non-infected fluid is present behind the tympanic membrane.

38
New cards

Acute Otitis Media

A rapid-onset middle ear pathology defined by the presence of infected fluid within the middle ear cavity.

39
New cards

Mucoid (Purulent) Otitis Media

A middle ear condition in which the tympanic cavity is filled with thick, purulent mucus or pus.

40
New cards

Glue Ear

A chronic presentation of middle ear effusion where the fluid becomes exceptionally thick and viscous, adhering directly to middle ear ossicles and structures.

41
New cards

Barotrauma (Tympanic Membrane)

Perforation or rupture of the tympanic membrane caused by rapid, extreme atmospheric pressure changes, such as from underwater diving or explosions.

42
New cards

Cholesteatoma

A benign, locally destructive pseudotumor in the middle ear space composed of desquamated epithelial cells and keratin.

43
New cards

Otosclerosis

An abnormal bone growth and remodeling disorder within the middle ear that fixes the stapes footplate in the oval window, producing conductive hearing loss.

44
New cards

Carhart's Notch

An artifactual sensorineural dip observed in bone conduction thresholds specifically at 2000 Hz2000\,\text{Hz} (2 kHz2\,\text{kHz}) in patients with otosclerosis, resolving after stapes mobilization.

45
New cards

Stapedectomy

A surgical intervention for otosclerosis involving excision of the immobilized stapes, sealing the oval window with a tissue or fat pad, and anchoring a prosthetic wire to the incus.

<p>A surgical intervention for otosclerosis involving excision of the immobilized stapes, sealing the oval window with a tissue or fat pad, and anchoring a prosthetic wire to the incus.</p>
46
New cards

Ossicular Discontinuity

The structural separation or disarticulation of the ossicular chain, secondary to physical trauma or tissue necrosis from chronic OME or cholesteatoma.

47
New cards

Glomus Tumor

A benign, highly vascularized, slow-growing middle ear tumor requiring surgical excision.

48
New cards

Noise-Induced Hearing Loss (NIHL)

A bilateral sensorineural hearing impairment caused by acoustic trauma or prolonged noise exposure, classically exhibiting a permanent 'noise notch' between 3000 to 6000 Hz3000\text{ to }6000\,\text{Hz}.

49
New cards

NIOSH Noise Exposure Standard

The National Institute for Occupational Safety and Health recommended maximum permissible occupational noise dosage of 8 hours8\,\text{hours} at 85 dB85\,\text{dB} within a 24-hour24\text{-hour} window.

50
New cards

OSHA Noise Exposure Standard

The Occupational Safety and Health Administration permissible exposure limit allowing a maximum dose of 8 hours8\,\text{hours} at 90 dB90\,\text{dB} within a 24-hour24\text{-hour} window.

51
New cards

Presbycusis

Progressive, age-related sensorineural hearing loss that initially compromises high frequencies before gradually spreading to lower spectral regions.

52
New cards

Meniere's Disease

An inner ear disorder resulting from endolymphatic hydrops (excess fluid volume in the scala media and vestibular labyrinth), typically causing fluctuating unilateral low-frequency sensorineural hearing loss, vertigo, and tinnitus.

53
New cards

Aminoglycoside Ototoxicity

Cochlear damage induced by potent broadband '-mycin' antibiotic drugs.

54
New cards

Chemotherapeutic Platinum Ototoxicity

Severe, irreversible sensorineural hearing damage caused by platinum-based chemotherapeutic agents (Cisplatin and Carboplatin), initiating as a precipitous high-frequency loss that progresses toward lower frequencies.

55
New cards

Loop Diuretic Ototoxicity

Hearing impairment caused by diuretic medications (e.g., Furosemide, Bumetanide) prescribed for edema, congestive heart failure, and renal disease.

56
New cards

Salicylate Ototoxicity

Cochlear toxicity resulting from high doses of anti-inflammatory medications like aspirin, typically producing a reversible, flat mild-to-moderate sensorineural hearing loss.

57
New cards

Acoustic Neuroma

A benign, slow-growing schwannoma on the vestibular division of Cranial Nerve VIII, classically presenting with unilateral high-frequency sensorineural hearing loss, poor word recognition, tinnitus, and abnormal ABR/acoustic reflex findings.

58
New cards

Central Auditory Processing Disorder (CAPD)

A neural deficit in auditory signal handling within the central nervous system that impairs processing of auditory stimuli along brain pathways, occurring independently of higher-order cognitive, language, or intellectual disorders.

59
New cards

Decoding Deficits (CAPD)

The 'truest' auditory-specific CAPD profile, localized to the left hemisphere or high brainstem, characterized by an inability to extract fine pitch, loudness, and timing cues, creating discrimination breakdown.

60
New cards

Integration Deficits (CAPD)

A cortical processing deficit marked by disrupted interhemispheric communication across the corpus callosum; patients cannot synthesize complex auditory information and become overwhelmed when multi-faceted data is presented rapidly.

61
New cards

Prosodic Deficits (CAPD)

A right-hemisphere central processing deficit marked by the inability to detect intonation contours, pitch rises and falls, or syllabic emphasis.

62
New cards

Diagnostic Criteria for CAPD Test Batteries

A clinical rule stating that if only a single test in a behavioral battery is abnormal, or conversely if all tasks across all tests fail, the condition is probably not true CAPD.

63
New cards

Bottom-Up CAPD Intervention

Stimulus-driven therapy focusing on auditory perceptual training, acoustic skill remediation, and environmental/assistive acoustic modifications.

64
New cards

Top-Down CAPD Intervention

Strategy-driven therapy utilizing cognitive, linguistic, and metacognitive compensatory techniques, educational modifications, and workplace accommodations.

65
New cards

Auditory Embryology: Month 1 & Month 2 (Peck Timeline)

In January (Month 1), the Eustachian tube begins forming; in February (Month 2), the vestibule separates from the cochlea, ossicular development begins, and the external canal starts developing.

66
New cards

Auditory Embryology: Month 3 to Month 5 (Peck Timeline)

In March (Month 3), inner and middle ear structures achieve adult form; in April–May (Months 4–5), cochlear hair cell differentiation occurs rapidly, and the fully formed ossicles begin ossifying.

67
New cards

Auditory Embryology: Month 6 to Month 8 (Peck Timeline)

In June (Month 6), the inner ear reaches near-adult size and the pinna attains adult form; in July (Month 7), initial auditory experiences occur and ossicles are nearly ossified; in August (Month 8), the tympanic cavity and ear canal open.

68
New cards

Usher Syndrome

The most common autosomal recessive syndromic hearing loss, presenting with sensorineural hearing loss and retinitis pigmentosa leading to progressive night blindness and visual field constriction.

69
New cards

Usher Syndrome Subtypes (USH1, USH2, USH3)

USH1 exhibits congenital severe-to-profound SNHL, vestibular dysfunction, and early night blindness; USH2 has congenital moderate-to-severe SNHL, normal vestibular function, and vision loss onset between ages 10 and 4010\text{ and }40; USH3 is progressive SNHL appearing in the third decade with variable vestibular and retinal deficits.

70
New cards

Waardenburg Syndrome

An autosomal dominant syndrome accounting for 1 to 3%1\text{ to }3\% of congenital hearing loss, marked by sensorineural loss and pigmentation anomalies of the iris, hair (white forelock), skin, and stria vascularis, classified into types W1–W4.

71
New cards

CHARGE Syndrome

An autosomal dominant disorder defined by Coloboma (iris/eyelid gap), Heart defects, Atresia of the choanae, Retarded growth/development, Genital abnormalities, and Ear/vestibular abnormalities.

72
New cards

Stickler Syndrome

A dominant or recessive hereditary connective tissue disorder involving collagen gene mutations, causing severe myopia, joint laxity, orofacial clefting, and sensorineural or conductive hearing loss.

73
New cards

Treacher Collins Syndrome

An autosomal dominant syndrome disrupting midface and mandibular tissue development, causing conductive hearing loss in approximately half of patients due to pinna microtia/atresia and ossicular dysmorphology.

74
New cards

Pendred Syndrome

The most prevalent autosomal recessive syndromic deafness condition, characterized by thyroid goiter and dysharmonic inner ear development, classically Mondini malformation.

75
New cards

Mondini Malformation

An incomplete cochlear partition malformation featuring an insufficient number of turns (fewer than the normal 2122\frac{1}{2} turns), associated with Pendred syndrome.

<p>An incomplete cochlear partition malformation featuring an insufficient number of turns (fewer than the normal $$2\frac{1}{2}$$ turns), associated with Pendred syndrome.</p>
76
New cards

Audiometric Candidacy for Hearing Aids

A minimum thresholds deficit of mild sensorineural loss across 500 to 4000 Hz500\text{ to }4000\,\text{Hz}, adequate word recognition scores, tolerable Loudness Discomfort Levels (LDL/UCL), and consideration of patient motivation and medical clearance.

77
New cards

Hearing Aid Fitting Workflow

The seven-step process comprising Assessment, Treatment Planning, Selection, Development, Verification, Orientation, and Validation.

78
New cards
<p>Real-Ear Verification (Probe Microphone Measurement)</p>

Real-Ear Verification (Probe Microphone Measurement)

The gold-standard objective verification technique where a thin silicone probe tube microphone is positioned inside the ear canal to measure exact sound pressure level (SPL) output delivered by the hearing aid.

79
New cards

Test Box Verification

An electroacoustic verification measure wherein the hearing aid is attached to a 2-cc2\text{-cc} ear simulator/coupler in an isolated, sound-treated chamber to estimate prescriptive gain compliance prior to patient placement.

80
New cards

Wide Dynamic Range Compression (WDRC)

A digital processing circuit that continuously regulates amplification, providing greater gain for low-intensity sounds and reduced gain for high-intensity sounds to preserve normal loudness perception without distortion.

81
New cards

Hearing Aid Data Logging

An onboard digital monitoring feature tracking daily hours of hearing aid wear, user volume adjustments, program selections, and listening acoustic environments.

82
New cards

Client Oriented Scale of Improvement (COSI)

A standardized clinical self-report outcome tool where patients identify specific listening goals prior to amplification and rate their degree of change and final listening ability over time.

<p>A standardized clinical self-report outcome tool where patients identify specific listening goals prior to amplification and rate their degree of change and final listening ability over time.</p>
83
New cards

Percutaneous Bone Anchored Implant (BAI)

A direct-drive bone conduction processor attached via a titanium abutment that protrudes through the skin, offering superior high-frequency sound transmission but carrying increased infection vulnerability.

84
New cards

Transcutaneous Bone Anchored Implant (BAI)

A skin-drive bone conduction processor attached via a magnetic coupling situated entirely beneath the intact scalp, having lower infection rates but experiencing attenuation of high-frequency energy.

85
New cards

Bone Anchored Implant (BAI) Candidacy

Patients with conductive or mixed hearing loss with an air-bone gap of at least 30 dB30\,\text{dB}, Single-Sided Deafness (SSD) acting as a CROS system, skull bone thickness of at least 2.5 mm2.5\,\text{mm}, and a minimum age of 5 years5\,\text{years}.

86
New cards

Middle Ear Implant (MEI) Candidacy

Adults exhibiting stable moderate-to-severe sensorineural hearing loss, word recognition scores between 40 to 60%40\text{ to }60\%, and anatomical or dermatological contraindications to conventional hearing aids.

87
New cards

Cochlear Implant (CI)

A surgically implanted neural prosthesis that bypasses outer, middle, and damaged cochlear hair cells to provide direct electrical stimulation to the auditory nerve (CN VIII).

88
New cards

Hybrid Cochlear Implant

A specialized device combining conventional acoustic amplification for preserved low-frequency hearing with electrical cochlear implant stimulation for non-functional high frequencies.

89
New cards

Cochlear Implant (CI) Candidacy Criteria

Patients at least 1 year1\,\text{year} of age with severe-to-profound bilateral sensorineural hearing loss receiving minimal benefit from traditional hearing aids, supported by CT or MRI verification of inner ear patency and auditory nerve presence.